Human T Lymphoid Progenitor
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus) Trial in Pessac, Paris (Human T Lymphoid Progenitor (HTLP)
Recruiting
- Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus)
- Human T Lymphoid Progenitor (HTLP) injection
-
Pessac, France
- +1 more
Oct 28, 2021
Pediatric Patients, Any Type of Severe Combined Immunodeficiency (SCID), Partial HLA Incompatible Allogeneic Hematopoietic Stem
Recruiting
- Pediatric Patients
- +2 more
- Human T Lymphoid Progenitor (HTLP) injection
-
Paris, Ile De France, FranceUnité d'Immunologie Hématologie Rhumatologie Pédiatrique (UIHR),
Apr 13, 2021
Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T
Recruiting
- Non Hodgkin Lymphoma
- +2 more
- Fully human anti CD19 CAR-T Cell Dose
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Oct 4, 2022
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
B-cell Acute Lymphoblastic Leukemia Trial in Nanchang (Human CD19 Targeted DASH CAR-T Cells Injection)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Human CD19 Targeted DASH CAR-T Cells Injection
-
Nanchang, Jiangxi, ChinaThe Second Affiliated Hospital of Nanchang University
Dec 13, 2022
Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
- Idiopathic CD4-Positive
- T-Lymphocytopenia
- Filgrastim
- Plerixafor
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)
Recruiting
- Living Donor Kidney Transplantation
- Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
-
Palo Alto, California
- +1 more
May 6, 2022
T Lymphoblastic Leukemia/Lymphoma, T-cell Acute Lymphoblastic Leukemia, Peripheral T Cell Lymphoma Trial in Shanghai (anti-CD7
Recruiting
- T Lymphoblastic Leukemia/Lymphoma
- +4 more
- anti-CD7 CAR-T cells
-
Shanghai, ChinaXianmin General Song
Aug 29, 2022
Acute Lymphoblastic Leukemia Trial in Shanghai (Human CD19-CD22 Targeted T Cells Injection)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- Human CD19-CD22 Targeted T Cells Injection
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Jan 24, 2022
T-Cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (CD5 CAR T (CT125B))
Recruiting
- T-Cell Acute Lymphoblastic Leukemia/Lymphoma
- CD5 CAR T (CT125B)
-
Beijing, Beijing, ChinaBeijing Gaobo Boren Hospital
Aug 3, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 12, 2023
Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19
Terminated
- Lymphoma, B-Cell
- +3 more
- Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2022
Non-Hodgkin's Lymphoma (Disorder), Acute Lymphoid Leukemia, Disease (Disorder) Trial in Louisville, Houston (1A46 Injection)
Recruiting
- Non-Hodgkin's Lymphoma (Disorder)
- Acute Lymphoid Leukemia, Disease (Disorder)
- 1A46 Injection
-
Louisville, Kentucky
- +1 more
Aug 1, 2022
CD19-positive, Acute Lymphoblastic Leukemia Trial in Shanghai (Human CD19 targeted T Cells Injection)
Recruiting
- CD19-positive
- Acute Lymphoblastic Leukemia
- Human CD19 targeted T Cells Injection
-
Shanghai, Shanghai, ChinaShanghai General Hospital
Aug 29, 2021
LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive
Recruiting
- LGLL - Large Granular Lymphocytic Leukemia
- +13 more
-
Duarte, California
- +9 more
Aug 9, 2022
Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)
Completed
- Leukemia
- Lymphoma
- Total Lymphoid Irradiation
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 28, 2022
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +14 more
- radiation therapy
- +8 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022
Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)
Recruiting
- Aplastic Anemia
- Bone Marrow Failure Syndrome
- Anti-Thymocyte Globulin (Rabbit)
- +8 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 26, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell
Completed
- Acute Lymphoblastic Leukemia in Remission
- +6 more
- Allogeneic Bone Marrow Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 15, 2021
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-80948543)
Recruiting
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
-
Duarte, California
- +18 more
Aug 11, 2022
Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte
Recruiting
- Lymphoid Leukemia, Acute
- +2 more
- T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc
May 24, 2022
Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in London (NVG-111, NVG-111 (RP2D))
Recruiting
- Chronic Lymphocytic Leukaemia
- +2 more
- NVG-111
- NVG-111 (RP2D)
-
London, United KingdomUniversity College London Hospital
Jun 22, 2021
Leukemia, Acute Trial in New York (Allogeneic T cell progenitors, cultured ex-vivo)
Recruiting
- Leukemia, Acute
- Allogeneic T cell progenitors, cultured ex-vivo
-
New York, New YorkMemorial Sloan Kettering Cancer Center (MSKCC)
Dec 9, 2021